Premium
Comfrey: assessing the low‐dose health risk
Author(s) -
Abbott Peter J.
Publication year - 1988
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1988.tb120821.x
Subject(s) - pyrrolizidine , health risk , medicine , environmental health , traditional medicine , toxicology , biology , bioinformatics
The regular use of comfrey as part of the diet or for medicinal purposes may be a potential health risk as a result of the presence of naturally‐ occurring pyrrolizidine alkaloids. The majority of these alkaloids are hepato‐ toxic in both animals and humans, and some have been shown to induce tumours in experimental animals. In this article, the toxic properties of pyrrolizidine alkaloids are reviewed briefly, with particular reference to their presence in comfrey. The acute and long‐term health risks at the normally‐ iow levels of comfrey consumption are evaluated and discussed. On the basis of the data that are available currently, the small but significant longterm risk that is associated with the consumption of comfrey justifies the need to limit its intake. This is being achieved by controls under various state Poisons Acts, but also requires further education on the potential dangers of naturally‐occurring chemicals of plant origin.